Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. (2015)
Attributed to:
Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0137834
PubMed Identifier: 26382239
Publication URI: http://europepmc.org/abstract/MED/26382239
Type: Journal Article/Review
Volume: 10
Parent Publication: PloS one
Issue: 9
ISSN: 1932-6203